VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $3,434,000 | -24.7% | 19,252 | -6.2% | 0.22% | -11.6% |
| Q2 2015 | $4,559,000 | +3.9% | 20,521 | -7.1% | 0.25% | +6.8% |
| Q1 2015 | $4,386,000 | +22.2% | 22,082 | -12.0% | 0.23% | +35.3% |
| Q4 2014 | $3,589,000 | -89.8% | 25,082 | -90.6% | 0.17% | -89.9% |
| Q3 2014 | $35,090,000 | +4.3% | 267,454 | +0.3% | 1.71% | +7.8% |
| Q2 2014 | $33,642,000 | +35.1% | 266,746 | +41.2% | 1.58% | +31.7% |
| Q1 2014 | $24,906,000 | +8.8% | 188,922 | -3.1% | 1.20% | +9.9% |
| Q4 2013 | $22,886,000 | +10.5% | 194,941 | -1.8% | 1.09% | +2.0% |
| Q3 2013 | $20,715,000 | +16.7% | 198,549 | -3.7% | 1.07% | +12.1% |
| Q2 2013 | $17,752,000 | – | 206,224 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |